0001415889-24-019552.txt : 20240715 0001415889-24-019552.hdr.sgml : 20240715 20240715163037 ACCESSION NUMBER: 0001415889-24-019552 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240711 FILED AS OF DATE: 20240715 DATE AS OF CHANGE: 20240715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROTHBLATT MARTINE A CENTRAL INDEX KEY: 0001106578 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 241117630 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1000 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4-07152024_040715.xml X0508 4 2024-07-11 0001082554 UNITED THERAPEUTICS Corp UTHR 0001106578 ROTHBLATT MARTINE A C/O UNITED THERAPEUTICS CORPORATION 1000 SPRING STREET SILVER SPRING MD 20910 true true false false Chairperson & CEO 1 Common Stock 2024-07-11 4 M 0 3600 129.49 A 3730 D Common Stock 2024-07-11 4 S 0 856 324.2504 D 2874 D Common Stock 2024-07-11 4 S 0 990 325.5661 D 1884 D Common Stock 2024-07-11 4 S 0 1159 326.5968 D 725 D Common Stock 2024-07-11 4 S 0 454 327.5886 D 271 D Common Stock 2024-07-11 4 S 0 141 328.7276 D 130 D Common Stock 2024-07-12 4 M 0 3600 129.49 A 3730 D Common Stock 2024-07-12 4 S 0 184 321.1773 D 3546 D Common Stock 2024-07-12 4 S 0 507 323.0178 D 3039 D Common Stock 2024-07-12 4 S 0 1248 324.2631 D 1791 D Common Stock 2024-07-12 4 S 0 694 325.1754 D 1097 D Common Stock 2024-07-12 4 S 0 501 326.4138 D 596 D Common Stock 2024-07-12 4 S 0 148 327.9074 D 448 D Common Stock 2024-07-12 4 S 0 213 328.4721 D 235 D Common Stock 2024-07-12 4 S 0 105 329.794 D 130 D Common Stock 166 I By Spouse Common Stock 245909 I By Trust Common Stock 1742 I By Trust Common Stock 28170 I By Trust Common Stock 324518 I By Trust Common Stock 45596 I By Trust Stock Options 129.49 2024-07-11 4 M 0 3600 0 D 2014-12-31 2024-12-31 Common Stock 3600 111869 D Stock Options 129.49 2024-07-12 4 M 0 3600 0 D 2014-12-31 2024-12-31 Common Stock 3600 108269 D This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. This transaction was executed in multiple trades at prices ranging from $324.03 to $324.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $325.10 to $326.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $326.10 to $327.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $327.24 to $327.995. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $328.70 to $328.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $321.38 to $322.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $322.78 to $323.215. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $323.78 to $324.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $324.89 to $325.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $325.90 to $326.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $327.225 to $328.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $328.26 to $328.925. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $329.785 to $329.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. Since the date of her last Form 4 filing, the reporting person has been replaced as the trustee of a trust which held 964 shares of Common Stock. The reporting person no longer has any reportable beneficial interest in those shares. Shares held in family trusts as to which the Reporting Person is sole trustee and members of the Reporting Person's immediate family are beneficiaries. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries. /s/ John S. Hess, Jr. under Power of Attorney 2024-07-15